Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

Aromatherapy for Dementia

Dementia Treatment

Alzheimer's Disease and the Microbiome

Pollution and Alzheimer's

Designing Dementia-Friendly Environments

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Mixed Dementia Prevention and Treatment

Coconut Oil and Dementia

Diet and Alzheimer's Disease

Stress and Alzheimer's Disease

Alzheimer's Disease Causes

See more featured articles »

Stem Cell Therapy for Alzheimer's

Antibody Research and Alzheimer’s Disease

Dementia Symptoms

Dementia Diagnosis

Mixed Dementia Symptoms and Diagnosis

Does Depression and Anxiety Increase the Risk of Dementia?

Childhood Dementia Causes

Alzheimer’s Disease and Calcium Supplements

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Alzheimer’s Disease and Gingko Biloba

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

What is Dementia?

AAM - Air pollution and Alzheimer's

Types of Alzheimer's Disease

Alzheimer's Disease Symptoms

Integrated PET/MR for Alzheimer’s Disease

Alzheimer's Disease and Sleep Disruption

Alzheimer’s tangles and plaques: what’s the difference?

Antidepressants and Dementia: Is There a Link?

What is Mixed Dementia?

Alzheimer's and Veganism

Dancing Through Dementia: How Movement Aids Memory and Mood

Inflammation and Alzheimer's Disease

Alzheimer's Disease Epidemiology

Biomarkers for Alzheimer's Disease

Transcutaneous Electrical Nerve Stimulation for Dementia

Bright Light Therapy and Dementia

AAM - Genetics of Alzheimer's

Does Herpesvirus Cause Alzheimer's?

Childhood Dementia Signs and Symptoms

Differences Between Alzheimer's and Dementia

Migraines and Dementia

Alzheimer's Disease Treatments

Alzheimer's Disease Diagnosis

Omega-3 and Alzheimer’s Disease

Amyloid Cascade Hypothesis

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Can Statins Protect Against Alzheimer’s Disease?

Mythbusting: Misconceptions in Dementia

What Causes Dementia?

Dementia with Lewy Bodies

Alzheimer's Disease Questions

What are Amyloid Plaques?

Alzheimer's Disease Prevention

Dementia Prevention

Is Alzheimer's Disease Transmissible?

Can Happiness Protect You from Dementia?

Gender and Alzheimer’s Risk

AAM - The Search for a Cure to Alzheimer's

Latest Alzheimer's & Dementia News and Research

Oral arginine reduces amyloid buildup in Alzheimer’s models

Alzheimer's disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid β (Aβ) have recently been developed, their clinical effectiveness remains limited.

21 Nov 2025

Astrocyte-driven approach shows potential to reverse cognitive decline in Alzheimer’s

Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer's disease and preserves cognitive function.

21 Nov 2025

Changes in brain fats play a key role in Alzheimer's development and progression

More than a century ago, Alois Alzheimer noted unusual changes in brain fats, which he described as "lipoid granules," along with the buildup of amyloid-beta (amyloid) plaques and tau protein tangles.

20 Nov 2025

Midlife exercise cuts dementia risk by up to 45 percent, new study shows

Higher physical activity in midlife and late life is linked to a substantially lower risk of all-cause and Alzheimer’s dementia. Midlife benefits are strongest for moderate or heavy activity, while late-life activity is protective across all intensity levels.

20 Nov 2025

Study reveals how aging reshapes protein chemistry in the brain

A study by the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) in Jena shows that the chemical composition of proteins in the brain undergoes fundamental changes with aging.

20 Nov 2025

Evaluating whether LIT supplementation slows cognitive decline in Alzheimer’s patients

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline such as memory loss and behavioral disturbances that severely impair quality of life. Despite decades of research, effective disease-modifying therapies remain elusive, underscoring the urgent need for novel neuroprotective strategies.

19 Nov 2025

Clogged brain drains may signal early Alzheimer's risk

"Drains" in the brain, responsible for clearing toxic waste in the organ, tend to get clogged up in people who show signs of developing Alzheimer's disease, a study by researchers from Nanyang Technological University, Singapore (NTU Singapore) has discovered.

19 Nov 2025

Study links obesity severity to escalating cardiometabolic and renal disease burden

Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by researchers at Pennington Biomedical Research Center. Recently published in Obesity, the paper "Association of Obesity Severity with Cardiometabolic and Renal Disease Burden in the United States," explored the relationship through a cross-sectional study of data from the U.S. Behavioral Risk Factor Surveillance System survey.

18 Nov 2025

Muscle-driven gene therapy shows promise for protecting memory in Alzheimer’s

Alzheimer's disease (AD) is a devastating cause of memory loss and cognitive decline, for which no curative treatment is available.

18 Nov 2025

Scottish Brain Sciences opens new Alzheimer’s clinical research center at ONE Biohub

Scottish Brain Sciences (SBS), a leading clinical research organization dedicated to transforming the early detection and treatment of Alzheimer's disease and other neurodegenerative conditions, today announced that it has opened a new state-of-the-art clinical research center at ONE BioHub, Aberdeen.

17 Nov 2025

Study reveals widespread use of burdensome interventions for older dementia patients in Singapore

A new study by researchers from Duke-NUS Medical School has revealed that almost all community-dwelling older adults with advanced dementia in Singapore experience at least one potentially burdensome intervention in their last year of life.

17 Nov 2025

Reclassifying wine intake reshapes the Mediterranean diet’s cognitive impact

Higher adherence to the Mediterranean diet was not associated with better cognition when wine was scored as a “beneficial” component. When wine was reverse scored, Mediterranean diet adherence showed a modest positive association with MMSE performance and a borderline link with MoCA in Portuguese older adults at high dementia risk.

17 Nov 2025

Hypertension may induce early gene expression changes in brain cells

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.

14 Nov 2025

New insights into glioblastoma survival linked to brain fluid dynamics

Glioblastoma-the most aggressive form of brain cancer-remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after diagnosis.

14 Nov 2025

Empowering early detection of dementia with a dual approach involving AI and patient input

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer's disease and dementia are major reasons for lack of recognition of the condition.

13 Nov 2025

TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 12 Nov 2025

Income and social disparities found to influence dementia risk factors

People with lower incomes and people from racial and ethnic historically underrepresented groups in clinical studies are more likely to have modifiable risk factors for dementia, factors that could be changed to lower their risk, according to a study published November 12, 2025, in Neurology, the medical journal of the American Academy of Neurology.

12 Nov 2025